Giardia lambia intestinal infection is a common cause of diarrhea not only in Pakistan but around the world. It is believed to be a significant cause of morbidity and mortality in the pediatric age group. Aim: The aim of the study was to test the effectiveness of Nitazoxanide treatment in children with diarrhea caused by G. lambia. Methods: A total of 50 children with diarrhea caused by G. intestinalis received a 3-day nitazoxanide therapy (10 mg / kg / day in 2 doses for 3 days). Patients were monitored for clinical response 7 days after initiation of treatment, and then a stool sample was collected for parasitology and lamblia antigen testing. Results: Diarrhea resolved in all 50 (100%) children treated with nitazoxanide prior to the 7...
According to the WHO, giardiasis incidence rate in children in the world is 15 to 20%. In Russia, ov...
A prospective randomized, double-blind, placebo-controlled study was conducted in 50 adults and 50 c...
The adverse effects and treatment failures to some of the currently recommended drugs for giardia in...
A prospective randomized, double-blind, placebo-controlled study was conducted to assess the efficac...
Rotavirus is a leading cause of morbidity and mortality in children younger than 5 years. This study...
This study was designed to compare the treatment efficacy of single dose of ornidazole with 5 d trea...
Diarrheal disease is a leading cause of illness and death in children worldwide. Diarrhea is caused ...
Five-nitroimidazole (5-NI) compounds are among the most commonly used medications in the treatment o...
BACKGROUND & OBJECTIVE: As Rota virus leads to significant morbidity in children 2 months to 5 year...
Background: Giardiasis is the commonest intestinal protozoal infection worldwide. The current first-...
Abstract. The purpose of this study was to evaluate the efficacy and the tolerance of nitazoxanide i...
Background: Giardia duodenalis is among the commonest protozoan parasites in the intestinal tract of...
Giardiasis is one of the most common causes of diarrheal disease worldwide and 5-nitroimidazoles (5-...
The adverse effects and treatment failures to some of the currently recommended drugs for giardia in...
Background: There is little evidence in the management of refractory giardiasis after treatment with...
According to the WHO, giardiasis incidence rate in children in the world is 15 to 20%. In Russia, ov...
A prospective randomized, double-blind, placebo-controlled study was conducted in 50 adults and 50 c...
The adverse effects and treatment failures to some of the currently recommended drugs for giardia in...
A prospective randomized, double-blind, placebo-controlled study was conducted to assess the efficac...
Rotavirus is a leading cause of morbidity and mortality in children younger than 5 years. This study...
This study was designed to compare the treatment efficacy of single dose of ornidazole with 5 d trea...
Diarrheal disease is a leading cause of illness and death in children worldwide. Diarrhea is caused ...
Five-nitroimidazole (5-NI) compounds are among the most commonly used medications in the treatment o...
BACKGROUND & OBJECTIVE: As Rota virus leads to significant morbidity in children 2 months to 5 year...
Background: Giardiasis is the commonest intestinal protozoal infection worldwide. The current first-...
Abstract. The purpose of this study was to evaluate the efficacy and the tolerance of nitazoxanide i...
Background: Giardia duodenalis is among the commonest protozoan parasites in the intestinal tract of...
Giardiasis is one of the most common causes of diarrheal disease worldwide and 5-nitroimidazoles (5-...
The adverse effects and treatment failures to some of the currently recommended drugs for giardia in...
Background: There is little evidence in the management of refractory giardiasis after treatment with...
According to the WHO, giardiasis incidence rate in children in the world is 15 to 20%. In Russia, ov...
A prospective randomized, double-blind, placebo-controlled study was conducted in 50 adults and 50 c...
The adverse effects and treatment failures to some of the currently recommended drugs for giardia in...